Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children - A population-based study

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Jokinen, Jukka ^a   Rinta Kokko, Hanna ^a   Siira, Lotta ^a   Palmu, Arto A ^a   Virtanen, Mikko J ^a   Nohynek, Hanna ^a   Virolainen Julkunen, Anni ^b   Toropainen, Maija ^a   Nuorti, J Pekka ^a,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Sosiaali ja terveysministerio   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CHILD; CONTROLLED STUDY; FINN (CITIZEN); FOLLOW UP; HUMAN; INFECTION PREVENTION; INFECTION RATE; OBSERVATIONAL STUDY; PNEUMOCOCCAL INFECTION; CASE CONTROL STUDY; EVALUATION STUDY; FEMALE; FINLAND; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; VACCINATION;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINATION;

EID: 84924937715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120290     Document Type: Article

References (29)

1. Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreno RA, Nohynek H, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009; 4: CD004977
2. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010; 201: 32-41. doi: 10.1086/648593 PMID: 19947881
3. Miller E, Andrews NJ, Waight P, Slack M, George R. Herd immunity and serotype replacement four years after pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011; 11: 760-8. doi: 10.1016/S1473-3099(11)70090-1 PMID: 21621466
4. Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet 2013; 381(9862): 214-22. doi: 10.1016/S0140-6736(12)61854-6 PMID: 23158882
5. Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, et al. Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial. PLoS Med. 2014; 11(6): e1001657. doi: 10.1371/journal.pmed.1001657 PMID: 24892763
6. De Wals P, Lefebvre B, Defay F, Deceuninck G, Boulianne N. Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine 2012; 30:6416-20. doi: 10.1016/j.vaccine.2012.08.017 PMID: 22921290
7. De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, et al. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine 2014; 32: 1501-1506 doi: 10.1016/j.vaccine.2013.11.028 PMID: 24486346
8. Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, et al. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med. 2014; 2(6): 464-71. doi: 10.1016/S2213-2600(14)70060-8 PMID: 24726406
9. Jokinen J, Sundman J, Baum U, Jääskeläinen S, Ruokokoski E, Leino T, et al. Finnish National Vaccination Register - ten years in the making. Nordic Vaccine Meeting, Bergen, Norway 2014. Available: http://www.fhi.no/dokumenter/ce5fe2c0b8.pdf. Accessed 2014 Apr 24.
10. Nuorti P, Nohynek H, Heikkinen T,Salo H, Hulkko T, Koivula I, et al. Lasten pneumokokkitautien ehkäisy rokotuksin. Suomen lääkärilehti 30-32/2002 vsk 57 (in Finnish). PMID: 15700581
11. Klemets P, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti P. Invasive pneumococcal infections among persons with and without underlying medical conditions: Implications for prevention strategies. BMC Infect Dis. 2008; 8: 96 doi: 10.1186/1471-2334-8-96 PMID: 18647385
12. Siira L, Kaijalainen T, Lambertsen L, Nahm MH, Toropainen M, Virolainen A. From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping. J Clin Microbiol. 2012; 50(8): 2727-31. doi: 10.1128/JCM.00689-12 PMID: 22692742
13. Palmu AA, Jokinen J, Nieminen H, Syrjänen R, Ruokokoski E, Puumalainen T, et al. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial. The Lancet Respir Med. 2014; 2(9): 717-27. doi: 10.1016/S2213-2600(14)70139-0 PMID: 25127244
14. nd ed. London: Chapman & Hall; 2002.
15. nd ed. New York: John Wiley & Sons; 2004.
16. Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, Kaijalainen T, et al. Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006. Antimicrob Agents Chemother. 2009; 53(5): 2066-73. doi: 10.1128/AAC.01464-08 PMID: 19273677
17. Klemets P, Lyytikäinen O, Ruutu P, Kaijalainen T, Leinonen M, Ollgren J, et al. Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis. 2008; 40(8): 621-8. doi: 10.1080/00365540801938931 PMID: 18979600
18. Hanage WP, Finkelstein JA, Huang SS, Pelton SI, Stevenson AE, Kleinman K, et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010; 2(2): 80-4. doi: 10.1016/j.epidem.2010.03.005 PMID: 21031138
19. Gray B, Turner M, Dillon H. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carrige in the first 24 months of life. Am J Epid. 1982; 116(4): 692-702. PMID: 7137156
20. Bogaert D, de Groot R, Hermans P. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis. 2004; 4: 144-54. PMID: 14998500
21. Käyhty H, Auranen K, Nohynek H, Dagan R, Mäkelä H. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines 2006; 5(5): 651-67. PMID: 17181439
22. th International Symposium on Pneumococci and Pneumococcal Diseases, Hyderabad, India 2014. Available: http://isppd.meetingxpert.net/swf/poster-viewer.aspx. Accessed 2014 Mar 13.
23. Martinelli D, Pedalino B, Cappelli MG, Caputi G, Sallustio A, Fortunato F, et al. Towards the 13-valent pneumococcal conjugate universal vaccination: Effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013. Hum Vaccin Immunother. 2014; 10(1): 33-9. doi: 10.4161/hv.26650 PMID: 24096297
24. Lim GH, Wormsbecker AE, McGeer A, Pillai DR, Gubbay JB, Rudnick W, et al. Have changing pneumococcal vaccination programmes impacted disease in Ontario? Vaccine 2013; 31(24): 2680-5. doi: 10.1016/j.vaccine.2013.04.007 PMID: 23597716
25. Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis. 2013; 19(1): 61-8. doi: 10.3201/eid1901.120741 PMID: 23259937
26. Harboe ZB, Dalby T, Weinberger DM, Benfield T, Mølbak K, Slotved HC, et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014; 59(8):1066-73. doi: 10.1093/cid/ciu524 PMID: 25034421
27. th International Symposium on Pneumococci and Pneumococcal Diseases, Hyderabad, India 2014.
28. Mereckiene J, Fitzgerald M, Cotter S, Corcoran M, Humphreys H, Vickers I, et al. Invasive pneumococcal disease (IPD) and effect of pneumococcal conjugate vaccines in Ireland in 2008-2013. ESCAIDE, Stockholm, Sweden 2014. Available: http://ecdc.europa.eu/en/ESCAIDE/programme/presentations/.
29. Jokinen J, Nohynek H, Nuorti P, Palmu AA, Siira L, Virolainen-Julkunen A, et al. Monitoring the population effectiveness of pneumococcal conjugate vaccination in the Finnish national vaccination programme - Surveillance system and analysis description. THL report 34/2012. Available http://urn.fi/URN:ISBN:978-952-245-652-6.